A 30-kDa DNA topoisomerase has been purified to near homogeneity from the purple nonsulfur photosynthetic bacterium Rhodobacter capsulatus. The enzyme is recognized by an antibody against a 16-mer peptide sequence from human DNA topoisomerase I. The purified enzyme is a type I topoisomerase. Consistent with the properties of other prokaryotic type I DNA topoisomerases, the isolated enzyme is unable to relax positively supercoiled DNA and absolutely requires divalent cations for its relaxation activity. However, regardless of the Mg ؉2 concentrations, ATP concentrations above 5 mM completely inhibit the relaxing activity. The enzyme is sensitive to high salt concentrations and the optimal activity occurs at salt concentrations between 3 and 30 mM for monovalent cations. Single-stranded M13 DNA is a strong inhibitor of this relaxing activity. The enzyme is inhibited by ethidium bromide, confirming that this DNA topoisomerase is incapable of relaxing positive supercoils. Topoisomerase I-specific inhibitors like Hoechst 32258 and actinomycin D inhibit the enzymatic activity while the enzyme is resistant to type II topoisomerase inhibitors such as norfloxacin, nalidixic acid, and novobiocin. From these enzymatic characteristics, we conclude that the R. capsulatus DNA topoisomerase is a prokaryotic type I DNA topoisomerase.
DNA topoisomerases are enzymes that control and modify the topological states of DNA by catalyzing the concerted breakage and reunion of DNA strands (for reviews see Refs. 1, 2). There are two major types of DNA topoisomerases in nature that are classified as type I and type II enzymes, depending on whether a single-stranded or double-stranded DNA break occurs during the enzymatic catalysis (3) . As a consequence of a difference in mechanism of action, type I DNA topoisomerases change the linking number (Lk) in sequential steps of one turn, whereas type II enzymes alter the Lk in steps of two turns (1) .
Type I DNA topoisomerases are ubiquitous, having been found in every prokaryotic or eukaryotic cell so far examined. Even though the prokaryotic and eukaryotic enzymes share some properties, they are fundamentally different and are not evolutionarily related (4) . Type I DNA topoisomerases can be subdivided into two nonrelated groups. Group A is composed of enzymes that make a transient covalent complex with the 5Ј end of the broken DNA strand. These enzymes can act on negatively, but usually not on positively, supercoiled DNA and they are inhibited by single-stranded competitor DNA (5) (6) (7) (8) . In addition, a divalent cation, usually Mg ϩ2 , is required for the relaxation activity. This group consists of the prokaryotic enzymes and the DNA topoisomerase III of yeast (5) .
In contrast, Group B is composed of eukaryotic DNA topoisomerases, which include enzymes that form a covalent intermediate with the 3Ј end of the DNA while relaxing both positive and negative supercoils. Divalent cations are not required for the relaxing activity of Group B enzymes (5, 9) .
Although detailed knowledge about the role of DNA topoisomerases in vivo is still lacking, it is reasonable to assume that they are key enzymes in the control of DNA conformation with a corresponding influence on replication, transcription, and recombination (2, 10) . In the bacterial genome, in particular, the topological state of DNA acts as a driving force and functional regulator for several metabolic activities (11) . In addition, the topological state of DNA has recently been implicated as a determining factor in the transcription of specific classes of genes such as anaerobically and aerobically expressed genes (12) (13) (14) (15) as well as of other genes which are activated under stress conditions (e.g., osmotic changes) (16) .
Rhodobacter capsulatus is a facultative Gram-negative bacterium capable of growing either aerobically in the dark or anaerobically in the light (17) (18) investigated a hypothesis in which the DNA superhelicity in the region of the genes for photosynthesis is altered, leading to a selective repression or derepression of their transcription. On the contrary, more recent results in our laboratory indicate that the requirement for DNA gyrase in the transcription of anaerobically induced genes may result from the topological requirement for a DNA swivel near heavily transcribed regions of the chromosome (19, 20) . Consequently, the physiological significance of DNA supercoiling effects on specific gene regulation, not only in this bacterium but in other facultative phototrophs, is a controversial area for study.
This paper reports the purification and characterization of a novel ATP-independent type I DNA topoisomerase from R. capsulatus, to clarify and augment what is known about this crucial group of enzymes. Due to the importance of DNA topology in the mechanisms that trigger the expression of genes regulated under different environmental conditions, DNA topoisomerase I from R. capsulatus will provide an excellent tool for establishing the biological role of topoisomerases.
MATERIALS AND METHODS
Materials. Calf thymus topoisomerase I was purchased from Gibco BRL. Reagents for SDS-PAGE, 2 protein molecular weight standards, and BCIP/NBT Color Development for alkaline phosphatase were purchased from Bio-Rad. Phosphocellulose was purchased from Whatman, and Sepharose 4 fast flow was supplied by Pharmacia. PMSF was supplied by Calbiochem. CAPS, spermidine, heparin, N-ethylmaleimide, nalidixic acid, novobiocin, actinomycin D, and ethidium bromide were obtained from Sigma. Norfloxacin was purchased from Merck Sharp & Dohme. Yeast tRNA was purchased from Bethesda Research Laboratories. The PVDF membrane came from Applied Biosystems, and the nitrocellulose membrane (0.1 m) was from Schleicher and Schuell NC. The antibodies against 16-mer synthetic polypeptide from human topoisomerase were a gift from 2 Abbreviations used: PAGE, polyacrylamide gel electrophoresis; PMSF, phenylmethylsulfonyl fluoride; CAPS, 3-[Cyclohexylamino]-1-propanesulfonic acid; BCIP, 5-bromo-4-chloro-3-indolyl phosphate; NBT, nitroblue tetrazolium; PVDF, polyvinylidene difluoride; TCA, trichloroacetic acid; SDS, sodium dodecylsulfate. Dr. Mukherjee (21) . Calf thymus topoisomerase antibodies were a gift from Drs. D'Arpa and Liu (22) .
Topoisomerase assay. The standard assay mixture (20 l) contained 0.25 g of negatively supercoiled pUC18 DNA, 40 mM TrisHCl (pH 8.0), 30 mM NaCl, 4 mM MgCl 2 , 0.8 mM EDTA, 0.15 g/ml yeast tRNA (to inhibit contaminating endonucleases), and 2 l of the sample to be tested. The mixture was incubated for 30 min at 37°C and the products were analyzed by 1% agarose gel electrophoresis (2 h at 5.5 V/cm). After electrophoresis, the DNA was stained with ethidium bromide (0.5 g/ml) and photographed under UV illumination. The photographic negatives of the gels were acquired with a Polaroid MP-4 Land Camera. For quantitative assays, densitometric analysis of the negatives (see Densitometric analysis) were carried out.
One unit of activity was defined as the amount of enzyme required to relax 50% of the supercoiled pUC18 in the standard assay reaction.
DNA. Plasmid pUC18 was purified from Escherichia coli DH5␣ strain by standard alkaline-SDS lysis protocol and supercoiled DNA was isolated by buoyant CsCl-ethidium bromide density gradient centrifugation (23) . A unique topoisomer of pUC18 was obtained as described by Bouthier de la Tour et al. (9) . Positively supercoiled DNA from pUC18 was obtained by relaxing the plasmid with 7 units of calf thymus DNA topoisomerase I followed by incubation with ethidium bromide (1 g/ml).
Protein gel electrophoresis. Electrophoresis under denaturing conditions was performed in a 10% SDS-polyacrylamide gel as described by Laemmli (24) . Gels were stained using a Bio-Rad Silver Stain kit.
Protein determination. Soluble protein concentrations were measured by the procedure of Bradford (25) . Total protein was determined by the method described by Chang (26), followed by Lowry (27) measurement.
Bacterial strains and growth conditions. R. capsulatus SB1003 strain was grown in 1 liter of RCV medium (28) in a 2.8-liter flask at 30°C, with vigorous shaking for 4 days.
Purification of DNA topoisomerase I. Six liters of R. capsulatus cell suspension were harvested after 4 days of aerobic growth by centrifugation in a GS-3 Sorvall rotor at 4,225g for 30 min at 4°C. The pellet was washed once in 600 ml of 0.15 M KCl and centrifuged in a GS-3 Sorvall rotor at 6,000g for another 20 min at 4°C. The resultant cell pellet was dissolved in 240 ml of lysis buffer [25 mM Tris-HCl (pH 7.5), 0.15 M KCl, 10% (v/v) glycerol], and subsequently PMSF was added to a final concentration of 2 mM. The cell suspension was passed five times through a French pressure cell at 12,000 psi. The unbroken cells and cell debris were pelleted by two consecutive centrifugations; first, the lysate was centrifuged in a SS-34 Sorvall rotor at 8,700g for 20 min at 4°C and, subsequently, the supernatant was centrifuged for 30 min at 150,000g in a Beckman 50.2Ti rotor. Ammonium sulfate was added to the supernatant to 30% saturation and centrifuged at 8,700g for 20 min. The supernatant was retained and ammonium sulfate concentration increased to 60% saturation. The precipitate was pelleted by centrifugation and resuspended in 20 ml of TEMG buffer [20 mM Tris-HCl (pH 8.0), 1 mM EDTA, 10% (v/v) glycerol, 0.20 mM ␤-mercaptoethanol] and dialyzed against five 100-ml changes of the same buffer (Fraction I).
After removing the precipitate from the dialyzate by centrifuga- 
FIG. 3.
Western blot of proteins in various steps of purification. Lane M r : prestained protein molecular weight markers. Lane I: 7 g of protein from the ammonium sulfate precipitation. Lane II: 10 g of protein from Sepharose 4 fast flow preparation. The proteins were resolved in a 10% polyacrylamide denaturating gel. After transferring the proteins onto a 0.1 m nitrocellulose membrane, the membrane was probed with antibody to 16-mer polypeptide corresponding to the active residues of human DNA topoisomerase I.
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PURIFICATION AND CHARACTERIZATION OF DNA TOPOISOMERASE I tion, the solution was loaded in aliquots of 2 ml onto a Sepharose 4 fast flow column (25 ϫ 1.5 cm, Bio-Rad) equilibrated with the same buffer. After each loading, the column was washed with 60 ml of this buffer. Active fractions were combined and dialyzed against TEMG buffer containing 0.1 M NaCl (Fraction II).
Fraction II was applied to a phosphocellulose P11 column (15 ϫ 1.5 cm, Whatman), equilibrated with the dialysis buffer. After loading the sample, the column was washed with 3 column volumes of TEMG buffer containing 0.1 M NaCl. Topoisomerase I was eluted with a 100-ml linear gradient of 0.1-1.2 M NaCl. Fractions of 1 ml were collected and assayed for DNA relaxation activity, which was eluted between 0.7 and 0.9 M NaCl. Active fractions were pooled and concentrated threefold by filtering on YM30 membranes (Amicon). The sample was then dialyzed against TEMG buffer containing 0.3 M NaCl (Fraction III). Both Fractions II and III were stable at 4°C for 4 months.
Fraction III was loaded onto a POROS HE-2 column (crosslinked polystyrene/divinylbenzene coated with heparin) (PerSeptive Biosystems, Inc.) equilibrated with TEMG buffer containing 0.3 M NaCl. After washing with 10 column volumes (16 ml) of the same buffer, an 8-ml linear gradient of 0.3-1.2 M NaCl in TEMG buffer was applied. The active fractions (0.4 ml each) eluted between 0.3 and 0.55 M NaCl and were pooled (Fraction IV) and concentrated five times in Centricon 10 cartridges (Amicon). Fraction IV was stored at 4°C and remained active for at least 2 months. Studies of DNA topoisomerase I were done using this fraction.
Western blot. The proteins were electrophoresed in a 10% polyacrylamide denaturating gel and electrotransferred to a nitrocellulose membrane using the buffer described by Bjerrum and SchaferNielsen (29) . The blocking and incubation with antibodies were carried out as described in the procedure of Ausubel et al. (30) 
Densitometric analysis. For a quantitative assay, the negatives of the photographs were scanned by a Computing Densitometer 300S (Molecular Dynamics).
RESULTS AND DISCUSSION

Purification of R. capsulatus DNA Topoisomerase I
The enzyme was purified as summarized in Table I . DNA topoisomerase activity was associated with a protein band of M r 30,000, which was obtained with acceptable purity after three chromatographic steps (Fig. 1) .
The crude extract was obtained by homogenization of R. capsulatus cells using the French press. Supercoiled relaxation activity could not be tested immediately after French press extraction because of the presence of nucleases in the extract. This phenomenon has been also observed by other authors (7, 31) .
After R. capsulatus cultures were homogenized and centrifuged, 90% of DNA topoisomerase activity was recovered in the pellet precipitated at 30 -60% saturation of ammonium sulfate. The salted-out proteins were separated through a Sepharose 4 fast flow column yielding a minor peak followed by a major peak, with topoisomerase activity located in a narrow bank in the latter. At this step, although the active fractions contained many proteins (Fig. 1, lane II) , the relaxing activity was assayed without interference by nucleases.
The use of a phosphocellulose column resulted in the elimination of the majority of proteins (Fig. 1, lane III) with good recovery of topoisomerase (Table I ). The activity began eluting at 0.7 M NaCl and formed a broad trailing peak up to 0.9 M NaCl. The most active fractions eluted between 0.7 and 0.8 M NaCl. The final step of purification was chromatography of Fraction III over heparin column (HE-2), which separated the remaining extraneous proteins from topoisomerase to give a highly pure preparation of the enzyme. Relaxing activity elutes at 0.3 M NaCl in a sharp peak. Proteins in the fractions were separated in a 10% SDS-polyacrylamide gel ( Fig. 2A) and the intensity of the major band (M r 30,000) was correlated with the plasmid DNA relaxation activity shown in Fig. 2B . As observed in this Fig. 2 , there is not an exact correlation between intensity of the major band and the plasmid DNA relaxation activity. In this respect, the possibility that topoisomerase I activity is associated with more than one protein species could be considered. This fact has already been shown for another type I topoisomerase (32) . Nevertheless, as shown later, there is a clear recognition of the 30-kDa band by an antiserum against another type I topoisomerase, providing strong evidence for the identification of this protein. Further purification attempts using standard chromatographic techniques failed to recover DNA topoisomerase activity.
Densitometric analysis of the stained gel indicated that the purified 30-kDa protein constituted more than 80% of the total protein. However, faint protein bands were also present at M r 66,000 and 97,000 in Fraction IV.
The size of this polypeptide is quite distinct from most of the prokaryotic DNA topoisomerases so far studied which have a M r range from 75,000 to 112,000 (7, 9, 11, 33, 34) . Nevertheless, some of the eukaryotic counterparts (35, 36) as well as vaccinia virus DNA topoisomerase I (37) have approximately the same mass as the R. capsulatus enzyme. However, this atypical result might be caused during the purification process by accompanying proteases which generate an active proteolytic fragment from an initially larger protein. We do not believe that such an artifact has occurred since, even in the earlier steps of the purification (i.e., ammonium sulfate precipitation and Sepharose 4 fast flow), Western blot analysis identified a single band corresponding to a M r 30,000 product (Fig.  3) among a complex mixture of enzymes. In addition, the fact that in the presence of the antibodies recognizing the 30-kDa band the topoisomerase activity was inhibited appears to be a strong reason to conclude that the 30-kDa polypeptide does not result from a proteolytic cleavage of an initially larger DNA topoisomerase. Very similar Western bands were also detected when the antiserum against calf thymus DNA topoisomerase I (22) was used as the source of primary antibodies (data not shown).
The DNA Topoisomerase Is a Type I Enzyme
To determine whether the enzyme belongs to type I or type II DNA topoisomerases, we compared the linking number variations of a unique DNA topoisomer when incubated with Fraction IV of the purified enzyme or with the commercially available calf thymus DNA topoisomerase I, which changes the linking number of pUC18 in steps of one turn. Analysis of the topoisomer distribution by densitometry showed that the same profile was obtained with both enzymes (data not shown). Thus, by inference (38, 39), we conclude that the purified topoisomerase causes topological changes of DNA in steps of unity. Since this is a property of type I topoisomerases (1), we concluded that R. capsulatus DNA topoisomerase is a type I enzyme.
The type I activity of the R. capsulatus DNA topoisomerase was supported by the inhibitory effect of single-stranded DNA (33) . Single-stranded M13 DNA   FIG. 6 . Effect of temperature assay on R. capsulatus DNA topoisomerase I activity. Lane C: supercoiled pUC18 control. Reaction mixtures contained 2 l of Fraction IV and supercoiled pUC18 DNA (0.25 g) in standard reaction buffer. The mixtures were incubated for 30 min at different temperatures and the topoisomers were resolved in a 1% agarose gel.
FIG. 7.
Thermal stability of R. capsulatus DNA topoisomerase I. 2 l of Fraction IV was preincubated for different periods of time at the indicated temperatures in a standard reaction mixture without substrate (pUC18 DNA). After preincubation, samples were placed on ice for 5 min. Reactions were started by addition of 0.25 g of supercoiled pUC18 DNA and activity was measured after the samples were incubated for 30 min at 37°C. 128 strongly inhibited the relaxation of negatively supercoiled DNA (Table II) . A M13/pUC18 ratio of 0.1 (i.e., 25 ng of M13 in the reaction) was enough to inhibit the activity.
R. capsulatus DNA Topoisomerase Is Unable to Relax Positive Supercoils
Prokaryotic type I DNA topoisomerases differ from their eukaryotic counterparts by their inability to relax positively supercoiled DNA. In the experiment displayed in Fig. 4 , we show that R. capsulatus DNA topoisomerase I is not able to relax positively supercoiled DNA.
Relaxed DNA was incubated with ethidium bromide (1 g/ml) in the presence of calf thymus or R. capsulatus topoisomerase under standard assay conditions. After incubation for 30 min at 37°C, the ethidium bromide was extracted with n-butanol and the product samples were fractionated in a 1% agarose gel electrophoresis. If the topoisomerase had relaxed positive supercoils induced by ethidium bromide (40) , the DNA should have acquired negative supercoils after removal of the dye. If it failed, the product DNA should show no topological changes following extraction of the dye molecules.
Lane 2 of Fig. 4 shows that negatively supercoiled DNA (lane 1) molecules were relaxed by Fraction IV enzyme. In lanes 3 and 4, relaxed DNA molecules were used as the starting substrate, and calf thymus or R. capsulatus DNA topoisomerase I were tested, respectively. In lane 3, as expected, calf thymus topoisomerase produced supercoiled DNA after extraction of ethidium bromide, indicating that this enzyme is able to relax the initially positively supercoiled substrate. Lane 4 shows that DNA treated with R. capsulatus topoisomerase remains in the relaxed form after the removal of the intercalator, indicating that R. capsulatus DNA topoisomerase is unable to relax the initial positively supercoiled DNA.
Moreover, ethidium bromide, even at a concentration of 0.25 g/ml, completely inhibited the activity (Table  II) . This further indicates that the purified enzyme is only able to relax negatively supercoiled DNA and not the positive supercoils induced by the ethidium bromide-intercalation into the double helix (40) .
Biochemical Properties
The enzyme here purified absolutely requires divalent cations for its relaxing activity (Fig. 5A ), as occurs with other prokaryotic type I DNA topoisomerases (9, 41) . However, the range of activity appears to be narrower (2-8 mM MgCl 2 ) than that described for DNA topoisomerase I from Bifidobacterium breve and pea chloroplast (34, 41) , where the relaxing activity extends to 15 mM MgCl 2 . Also, both Ca ϩ2 and Mn ϩ2 can replace the effect of Mg ϩ2 , finding that the optimal concentrations of Ca ϩ2 and Mn ϩ2 were 4 -8 mM and 2-8 mM, respectively (Figs. 5C and 5D ). By contrast, Zn ϩ2 and Cu ϩ2 have no effect on DNA topoisomerase I activity (Fig. 5B) , as described for B. breve (41) and Aspergillus oryzae DNA topoisomerase I (42). Monovalent ions K ϩ and Na ϩ , while stimulating it at low concentrations (below 60 mM), inhibit DNA topoisomerase I activity above 150 mM (Fig. 5E ). This pattern coincides with most of the prokaryotic DNA topoisomerases (9, 34, 41) . By contrast, eukaryotic DNA topoisomerases are active at slightly higher concentrations (3, 5, 43) .
The enzyme is active over a broad range of temperatures, 25-60°C (Fig. 6) , with a peak activity at 45°C. As shown in Fig. 7 , the enzyme remains stable at 25°C (60% activity after 30 min) but at 45°C, the optimal temperature for activity, the thermal stability decreases rapidly. Less than 20% of the activity is retained after 30 min of preincubation at 45°C. After 15 min at 55°C, the enzyme is completely inactive (results not shown).
We found that a low concentration of ATP (1 mM) did not affect the activity, but at higher concentrations (Ͼ5 mM) ATP was a strong inhibitor of DNA topoisomerase I. Although enzymatic inhibition at higher ATP concentrations is characteristic of eukaryotic DNA topoisomerase I activity (44, 45) , this inhibitory effect has also been shown in some prokaryotic topoisomerases (9) where it was attributed to the chelation of Mg ϩ2 . However, in our work, we observed that the inhibitory effect of ATP is not related to Mg ϩ2 chelation. Therefore, ATP must have an inhibitory effect on R. capsulatus DNA topoisomerase I for reasons other than the chelation of Mg ϩ2 . The effect of some inhibitors on DNA topoisomerase I activity is shown in Table II . Actinomycin D and neomycin sulfate are known to inhibit E. coli topoisomerase I (46) . When examined, R. capsulatus DNA topoisomerase I was also completely inhibited by actinomycin D (10 g/ml) but not by neomycin sulfate (up to 50 g/ml). Other DNA topoisomerase I inhibitors, such as heparin (42, 47) , also inhibit R. capsulatus DNA topoisomerase I at 1 mg/ml. Besides, the DNA-aggregating agent spermidine inhibits R. capsulatus DNA topoisomerase I activity above 2.0 mM. The enzyme's inability to relax positively supercoiled DNA, and its inhibition by ethidium bromide and spermidine corresponds to the behavior of other prokaryotic type I DNA topoisomerases (9) . Also, the intercalator Hoechst 33258 inhibits the purified enzyme to the same extent as with other type I topoisomerases (42, 47) .
In contrast, topoisomerase II-specific inhibitors, namely novobiocin, nalidixic acid, and norfloxacin, did not affect the topoisomerase activity (Table II) .
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Finally, the enzyme was strongly inhibited by Nethylmaleimide (2.0 mM), suggesting that sulfhydryl groups were required for the enzyme activity. The above-mentioned characteristics, along with the fact that the purified enzyme is not inhibited by topoisomerase II specific inhibitors, indicate that R. capsulatus enzyme belongs to the prokaryotic type I class of DNA topoisomerases.
